Halozyme Therapeutics

Businesswoman ripping up contract

Biotech

Halozyme pulls Evotec bid after biotech was 'unwilling' to talk

Halozyme leaders tried to meet with the chairwoman of Evotec’s supervisory board, Iris Löw-Friedrich, M.D., Ph.D., but were rebuffed.

Darren Incorvaia Nov 22, 2024 10:46am

Diverse group of hands holding up US dollar banknotes of various denominations on green background - stock photo

Halozyme offers $2B for Evotec to expand beyond tech used by J&J

Nov 15, 2024 6:01am